Kemicare Products Profile
Key Indicators
- Authorised Capital ₹ 5.50 Cr
- Paid Up Capital ₹ 4.58 Cr
- Company Age 32 Year, 28 Days
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -9.01%
- Profit Growth -62.76%
- Ebitda -14.10%
- Net Worth -3.41%
- Total Assets -2.99%
About Kemicare Products
Kemicare Products Ltd (KPL) is a Public Limited Indian Non-Government Company incorporated in India on 25 January 1993 and has a history of 32 years. Its registered office is in Hooghly, West Bengal, India.
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.50 Cr and a paid-up capital of Rs 4.58 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Kemicare Products Ltd India is Pankaj Ringashia as CEO. Pankaj Ringashia, Sushma Verma, and Babita Ringashia serve as directors at the Company.
Company Details
- Location
Hooghly, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
L15142WB1993PLC057595
- Company No.
057595
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
25 Jan 1993
- Date of AGM
25 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Listed
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Kemicare Products?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pankaj Ringashia  | CEO | 16-Apr-2019 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pankaj Ringashia | Director and Ceo | 22-Dec-2017 | Current |
| Sushma Verma | Director | 07-Feb-2020 | Current |
| Babita Ringashia | Director | 07-Feb-2020 | Current |
Financial Performance of Kemicare Products.
Kemicare Products Ltd, for the financial year ended 2023, experienced Minor drop in revenue, with a 9.01% decrease. The company also saw a substantial fall in profitability, with a 62.76% decrease in profit. The company's net worth dipped by a decrease of 3.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kemicare Products?
In 2023, Kemicare Products had a promoter holding of 27.10% and a public holding of 72.91%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kemicare Products?
Unlock and access historical data on people associated with Kemicare Products, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kemicare Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kemicare Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
